Tag: TEER

NEW LATE-BREAKING DATA REINFORCE THE BENEFITS OF ABBOTT’S TRICLIP™ DEVICE FOR PEOPLE WITH TRICUSPID VALVE DISEASE

Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves Findings from the largest real-world dataset for tricuspid repair show device reduces tricuspid regurgitation and improves quality of life ABBOTT PARK, Ill., May 17, 2023 — Abbott […]

EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL

BOSTON, Sept. 17, 2022 /PRNewswire/ — Edwards Lifesciences Corporation ( NYSE: EW) announced results from CLASP IID, the first randomized controlled trial that directly compares two contemporary transcatheter edge-to-edge repair (TEER) therapies. The study confirms TEER as a safe and effective therapy in patients with degenerative mitral regurgitation (DMR). Results from the CLASP IID […]